Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 224,329Xls
2D Structure
Also known as: 3223-07-2, Melphalan hcl, Alkeran hydrochloride, Cb 3025 hydrochloride, Phenylalanine mustard hydrochloride, L-sarcolysine hydrochloride
Molecular Formula
C13H19Cl3N2O2
Molecular Weight
341.7  g/mol
InChI Key
OUUYBRCCFUEMLH-YDALLXLXSA-N
FDA UNII
1VXP4V453T

Melphalan Hydrochloride is a bifunctional alkylating agent and phenylalanine derivative of nitrogen mustard. Melphalan hydrochloride is converted into highly reactive ethylenimmonium intermediates that induce covalent guanine N7-N7 intra- and inter-crosslinks and alkylation of adenine N3 of DNA. This agent also alkylates RNA and protein structures. As a result RNA transcription and protein synthesis are inhibited, ultimately leading to cell growth arrest and/or death.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;hydrochloride
2.1.2 InChI
InChI=1S/C13H18Cl2N2O2.ClH/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19;/h1-4,12H,5-9,16H2,(H,18,19);1H/t12-;/m0./s1
2.1.3 InChI Key
OUUYBRCCFUEMLH-YDALLXLXSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl.Cl
2.1.5 Isomeric SMILES
C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl.Cl
2.2 Other Identifiers
2.2.1 UNII
1VXP4V453T
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 3223-07-2

2. Melphalan Hcl

3. Alkeran Hydrochloride

4. Cb 3025 Hydrochloride

5. Phenylalanine Mustard Hydrochloride

6. L-sarcolysine Hydrochloride

7. Sarcolysin Hydrochloride, L-

8. Alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, Monohydrochloride, L-

9. 1vxp4v453t

10. Cb-3025 Hydrochloride

11. Evomela

12. (2s)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic Acid;hydrochloride

13. L-phenylalanine Mustard Hydrochloride

14. 4-bis(2-chlorethyl)-amino-l-phenylalanine Hydrochloride

15. Alanine Nitrogen Mustard

16. Alkeran (tn)

17. L-phenylalanine, 4-(bis(2-chloroethyl)amino)-, Monohydrochloride

18. (s)-2-amino-3-(4-(bis(2-chloroethyl)amino)phenyl)propanoic Acid Hydrochloride

19. Nsc8806

20. Wln: Qvyz1r Dn2g2g &gh

21. Evomela (tn)

22. Melfalan Hydrochloride

23. Alkeran (glaxosmith)

24. L-alanine, Hydrochloride

25. Unii-1vxp4v453t

26. Schembl41335

27. Chembl1200863

28. Dtxsid60872785

29. L-phenylalanine, Monohydrochloride

30. Mfcd01674304

31. Alanine Nitrogen Mustard Hydrochloride

32. Akos025401785

33. Melphalan Hydrochloride [vandf]

34. Melphalan Hydrochloride [usp-rs]

35. Melphalan Hydrochloride [who-dd]

36. Ac-25549

37. Ai3-26377

38. Melphalan Hydrochloride [orange Book]

39. D08173

40. 223m072

41. Q27252967

42. 4-[bis(2-chloroethyl)-amino]-phenylalanine Hydrochloride

43. 4-[bis(2-chloroethyl)-amino]-l-phenylalanine Hydrochloride

44. L-3-(p-(bis(2-chloroethyl)amino)phenyl)alanine Monohydrochloride

45. L-alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, Hydrochloride

46. L-phenylalanine, 4-(bis(2-chloroethyl)amino)-, Hydrochloride (1:1)

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 341.7 g/mol
Molecular Formula C13H19Cl3N2O2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count8
Exact Mass340.051211 g/mol
Monoisotopic Mass340.051211 g/mol
Topological Polar Surface Area66.6 Ų
Heavy Atom Count20
Formal Charge0
Complexity265
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

High-dose of Phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:

- multiple myeloma,

- malignant lymphoma (Hodgkin, non-Hodgkin lymphoma),

- acute lymphoblastic and myeloblastic leukemia,

- childhood neuroblastoma,

- ovarian cancer ,

- mammary adenocarcinoma.

Phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (RIC) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-HSCT) in malignant haematological diseases in adults.

Phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:

- Myeloablative conditioning (MAC) treatment in case of malignant haematological diseases

- RIC treatment in case of non-malignant haematological diseases.


5 Pharmacology and Biochemistry
5.1 ATC Code

L01AA03